)
IGO (IGO) investor relations material
IGO AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Chair Vanessa Guthrie opened the Perth meeting after confirming a quorum; the AGM was also webcast, and the formal business followed shareholder questions.
The Chair said her FY 2026 review would cover safety, portfolio performance, strategic choices and governance; CEO Ivan Vella would address operations and strategy.
Financial performance review
Returned to profitability in FY 2026: NPAT AUD 145m, underlying EBITDA AUD 286m, underlying free cash flow AUD 134m; year-end cash AUD 387m.
Greenbushes recorded AUD 2.9bn revenue on a 100% basis despite challenges; its September quarter produced a record 435,000 tonnes of spodumene concentrate, with EBITDA margin of 83%.
Nova produced over 220,000 tonnes of nickel over nearly a decade and generated more than AUD 2.4bn in free cash flow and almost AUD 240m in royalties.
FY 2026 group TRIFR fell by more than 60%, with over 200 consecutive days without a recordable injury.
Board and executive committee updates
Board renewal included Vanessa Guthrie becoming Chair in January 2026; Michael Nossal, Debra Bakker and Samantha Hogg stepped down during the year.
Dean Jenkins joined in February 2026 and chairs People, Performance and Culture; Anthea McKinnell joined in September and chairs Audit and Risk.
The Board is now a six-member board, including Ivan Vella, with skills spanning mining, operations, project development, capital markets, M&A and governance.
- Record Greenbushes output and Nova’s final quarter supported $176.1M underlying EBITDA.IGO
Q1 2027 - Returned to profitability in FY26 with $145.3M NPAT, strong cash flow, and portfolio optimization.IGO
H2 2026 - Strong FY26 results with robust cash flow, improved safety, and Nova divestment announced.IGO
Q4 2026 - Revenue and EBITDA surged, but Greenbushes guidance was lowered amid operational challenges.IGO
Q3 2026 - Loss after tax improved to AUD 34 million, with stronger Nova EBITDA and cost discipline.IGO
H1 2026 - Net loss of $955M on 37% lower revenue, with impairments and market headwinds impacting results.IGO
H2 2025 - Revenue and profit fell sharply despite strong production, safety gains, and solid liquidity.IGO
H2 2024 - Strong FY24 cash generation and core-asset performance alongside portfolio changes.IGO
Q4 2024 - EBITDA loss driven by Kwinana and Nova, but Greenbushes delivered strong results.IGO
Q2 2025
)
)
)
)
)
)
)
)